Cited by 4,744Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer and biochemical research

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Regulation of cancer cell metabolism

Cairns, Rob A., Harris, Isaac S., Mak, Tak W.·2011·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Interest in the topic of tumour metabolism has waxed and waned over the past century of cancer research. The early observations of Warburg and his contemporaries established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. However, the initial hypotheses that were based on these observations proved inadequate to explain tumorigenesis, and the oncogene revolution pushed tumour metabolism to the margins of cancer research. In recent years, interest has been renewed as it has become clear that many of the signalling pathways that are affected by genetic mutations and the tumour microenvironment have a profound effect on core metabolism, making this topic once again one of the most intense areas of research in cancer biology.

Integrity signals

Registry

Crossref · 10.1038/nrc2981

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
The cancer genome
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625

Show all 142 references

Sorted by citations

Items 301–400 of 1,016

Cascade enzymes within self-assembled hybrid nanogel mimicked neutrophil lysosomes for singlet oxygen elevated cancer therapy
Wu, Q., He, Z., Wang, X., Zhang, Q., Wei, Q., Ma, S., Ma, C., Li, J., & Wang, Q. (2019) · Nature Communications · doi:10.1038/s41467-018-08234-2 · Cited by 224
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
Song, Y., Luo, Q., Long, H., Hu, Z. M., Que, T., Zhang, X., Li, Z., Wang, G., Liu, Y., Liu, Z., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-65 · Cited by 221
Cancer Cell MetabolismPreprint
Cairns, R. A., Harris, I. S., McCracken, S. A., & Mak, T. W. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.012856 · Cited by 229
Self-citation
Glycolytic Enzymes Coalesce in G Bodies under Hypoxic Stress
Jin, M., Fuller, G. G., Han, T., Yao, Y., Alessi, A. F., Freeberg, M. A., Roach, N. P., Moresco, J. J., Karnovsky, A., Baba, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.082 · Cited by 208
The role of lipid droplets and adipocytes in cancer. Raman imaging of cell cultures: MCF10A, MCF7, and MDA-MB-231 compared to adipocytes in cancerous human breast tissue
Abramczyk, H., Surmacki, J. M., Kopeć, M., Olejnik, A. K., Lubecka, K., & Fabianowska‐Majewska, K. (2015) · The Analyst · doi:10.1039/c4an01875c · Cited by 219
The Warburg metabolism fuels tumor metastasis
Lu, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09794-5 · Cited by 221
Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo
Zachar, Z., Marecek, J. F., Maturo, C., Gupta, S., Stuart, S. D., Howell, K. H., Schauble, A., Lem, J., Piramzadian, A., Karnik, S., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0785-8 · Cited by 222
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Gupta, S., Roy, A., & Dwarakanath, B. S. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 225
Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
Hayashi, Y., Yokota, A., Harada, H., & Huang, G. (2019) · Cancer Science · doi:10.1111/cas.13990 · Cited by 229
Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis
Pei, Z., Chen, S., Ding, L., Liu, J., Cui, X., Li, F., & Qiu, F. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.023 · Cited by 220
The metabolomic window into hepatobiliary disease
Beyoğlu, D., & Idle, J. R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.030 · Cited by 219
Glucose Oxidation Modulates Anoikis and Tumor Metastasis
Kamarajugadda, S., Stemboroski, L. N., Cai, Q., Simpson, N. E., Nayak, S., Tan, M., & Lu, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06248-11 · Cited by 222
Cancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 230
Tumor Microenvironment‐Enabled Nanotherapy
Wang, L., Huo, M., Chen, Y., & Shi, J. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201701156 · Cited by 215
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
Mele, L. L., Paino, F., Papaccio, F., Regad, T., Boocock, D. J., Stiuso, P., Lombardi, A., Liccardo, D., Aquino, G., Barbieri, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0635-5 · Cited by 215
GSH and H2O2 Co‐Activatable Mitochondria‐Targeted Photodynamic Therapy under Normoxia and Hypoxia
Sun, J. H., Du, K., Diao, J., Cai, X., Feng, F., & Wang, S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003895 · Cited by 215
Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification
Beyoğlu, D., Imbeaud, S., Maurhofer, O., Bioulac‐Sage, P., Zucman‐Rossi, J., Dufour, J., & Idle, J. R. (2013) · Hepatology · doi:10.1002/hep.26350 · Cited by 214
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
Antonioli, L., Yegutkin, G. G., Pacher, P., Blandizzi, C., & Haskó, G. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.01.003 · Cited by 218
Dichloroacetate and cancer: New home for an orphan drug?
Kankotia, S., & Stacpoole, P. W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.005 · Cited by 226
Targeting SOD1 reduces experimental non–small-cell lung cancer
Glasauer, A., Sena, L. A., Diebold, L. P., Mazar, A. P., & Chandel, N. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71714 · Cited by 215
NBD-based synthetic probes for sensing small molecules and proteins: design, sensing mechanisms and biological applications
Jiang, C., Huang, H., Kang, X., Yang, L., Xi, Z., Sun, H., Pluth, M. D., & Yi, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01096k · Cited by 212
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance
Chen, T., Xu, Z., Luo, J., Manne, R., Wang, Z., Hsu, C.-C., Pan, B., Cai, Z., Tsai, P., Tsai, Y.-S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.009 · Cited by 223
CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism
Ellis, B. C., Graham, L. D., & Molloy, P. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.10.016 · Cited by 209
Design of Hybrid MnO2‐Polymer‐Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment
Gordijo, C. R., Abbasi, A. Z., Amini, M. A., Lip, H. Y., Maeda, A., Cai, P., O'Brien, P. J., DaCosta, R. S., Rauth, A. M., & Wu, X. Y. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404511 · Cited by 211
Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?
Movahed, Z. G., Rastegari‐Pouyani, M., Mohammadi, M. H., & Mansouri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108690 · Cited by 214
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Cheng, X., Gao, J., Ding, Y., Lu, Y., Wei, Q., Cui, D., Fan, J., Li, X., Zhu, E., Lu, Y., et al. (2021) · Advanced Science · doi:10.1002/advs.202100876 · Cited by 209
Hypoxia-Inducible Factors Have Distinct and Stage-Specific Roles during Reprogramming of Human Cells to Pluripotency
Mathieu, J., Zhou, W., Xing, Y., Sperber, H., Ferreccio, A., Agoston, Z., Kuppusamy, K. T., Moon, R. T., & Ruohola‐Baker, H. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.012 · Cited by 217
Extracellular Acidic pH Activates the Sterol Regulatory Element-Binding Protein 2 to Promote Tumor Progression
Kondo, A., Yamamoto, S., Nakaki, R., Shimamura, T., Hamakubo, T., Sakai, J., Kodama, T., Yoshida, T., Aburatani, H., & Osawa, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.006 · Cited by 205
Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth
Larasati, Y. A., Yoneda‐Kato, N., Nakamae, I., Yokoyama, T., Meiyanto, E., & Kato, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20179-6 · Cited by 216
Microenvironmental pH and Exosome Levels Interplay in Human Cancer Cell Lines of Different Histotypes
Logozzi, M., Mizzoni, D., Angelini, D. F., Raimo, R. D., Falchi, M., Battistini, L., & Fais, S. (2018) · Cancers · doi:10.3390/cancers10100370 · Cited by 212
How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?
Lincet, H., & Icard, P. (2014) · Oncogene · doi:10.1038/onc.2014.320 · Cited by 212
Critical Functions of the Lysosome in Cancer Biology
Davidson, S. M., & Heiden, M. G. V. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103101 · Cited by 214
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium( iii ) complexes
Cao, J., Tan, C., Chen, M., Wu, N., Yao, D., Liu, X., Ji, L., & Mao, Z. (2016) · Chemical Science · doi:10.1039/c6sc02901a · Cited by 209
YB-1: oncoprotein, prognostic marker and therapeutic target?
Lasham, A., Print, C. G., Woolley, A. G., Dunn, S. E., & Braithwaite, A. W. (2012) · Biochemical Journal · doi:10.1042/bj20121323 · Cited by 206
Toward understanding the selective anticancer capacity of cold atmospheric plasma—A model based on aquaporins (Review)
Yan, D., Talbot, A., Nourmohammadi, N., Sherman, J. H., Cheng, X., & Keidar, M. (2015) · Biointerphases · doi:10.1116/1.4938020 · Cited by 214
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy
Salaroglio, I. C., Panada, E., Moiso, E., Buondonno, I., Provero, P., Rubinstein, M., Kopecka, J., & Riganti, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0657-0 · Cited by 216
Metabolite sensing and signaling in cell metabolism
Wang, Y.-P., & Lei, Q. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0024-7 · Cited by 208
Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
Makinoshima, H., Takita, M., Matsumoto, S., Yagishita, A., Owada, S., Esumi, H., & Tsuchihara, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575464 · Cited by 210
Roles of microRNA on cancer cell metabolism
Chen, B., Li, H., Zeng, X., Yang, P., Liu, X., Zhao, X., & Liang, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-228 · Cited by 206
Cooperation among cancer cells: applying game theory to cancer
Archetti, M., & Pienta, K. J. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0083-7 · Cited by 203
Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
Wang, S., Fu, J., Hao, H., Jiao, Y., Li, P., & Han, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105728 · Cited by 207
Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin
Zhang, L., & Wang, H. (2015) · Marine Drugs · doi:10.3390/md13074310 · Cited by 202
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
Shen, Y.-C., Ou, D., Hsu, C., Lin, K.-L., Chang, C.-Y., Lin, C.-Y., Liu, S., & Cheng, A.-L. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.559 · Cited by 202
Functional Metabolic Screen Identifies 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4 as an Important Regulator of Prostate Cancer Cell Survival
R�os, S., Santos, C. R., Moco, S., Baenke, F., Kelly, G. P., Howell, M. T., Zamboni, N., & Schulze, A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0234 · Cited by 201
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation
Lee, J.-H., Liu, R. R., Li, J., Wang, Y., Tan, L., Li, X.-J., Qian, X., Zhang, C., Xia, Y., Xu, D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.018 · Cited by 206
Dietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 213
Metabolite interactions between host and microbiota during health and disease: Which feeds the other?
Zhang, Y., Chen, R., Zhang, D., Qi, S., & Liu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114295 · Cited by 224
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer
Leithner, K., Hrzenjak, A., Trötzmüller, M., Moustafa, T., Köfeler, H. C., Wohlkoenig, C., Stacher, E., Lindenmann, J., Harris, A. L., Olschewski, A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.47 · Cited by 204
The role of peroxiredoxins in cancer
Nicolussi, A., D'inzeo, S., Capalbo, C., Giannini, G., & Coppa, A. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1129 · Cited by 210
The challenge of targeting cancer stem cells to halt metastasis
Agliano, A., Calvo, A., & Box, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.003 · Cited by 201
Antimitotic drugs in the treatment of cancer
van Vuuren, R. J., Visagie, M. H., Mercier, A. E., & Joubert, A. M. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2903-8 · Cited by 210
Graviola: A novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism
Torres, M. P., Rachagani, S., Purohit, V., Pandey, P., Joshi, S., Moore, E. D., Johansson, S. L., Singh, P. K., Ganti, A. K., & Batra, S. K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.031 · Cited by 202
Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy
Liu, Y., Ji, X., Tong, W. W. L., Askhatova, D., Yang, T., Cheng, H., Wang, Y. Z., & Shi, J. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201710144 · Cited by 201
Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models
Eichner, L. J., Brun, S. N., Herzig, S., Young, N. P., Curtis, S. D., Shackelford, D. B., Shokhirev, M. N., Leblanc, M., Vera, L. I., Hutchins, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.005 · Cited by 194
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
Fendt, S., Bell, E. L., Keibler, M. A., Davidson, S. M., Wirth, G. J., Fiske, B. P., Mayers, J. R., Schwab, M. G., Bellinger, G., Csibi, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0080 · Cited by 196
Photoacoustic Imaging in Oncology: Translational Preclinical and Early Clinical Experience
Valluru, K., Wilson, K. E., & Willmann, J. K. (2016) · Radiology · doi:10.1148/radiol.16151414 · Cited by 197
Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers
Nath, A., & Chan, C. (2016) · Scientific Reports · doi:10.1038/srep18669 · Cited by 202
Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system
Hari, S. K., Gauba, A., Shrivastava, N., Tripathi, R. M., Jain, S. K., & Pandey, A. K. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01197-4 · Cited by 200
Targeting Protein-Protein Interaction by Small Molecules
Jin, L., Wang, W., & Fang, G. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140028 · Cited by 195
Tumour predisposition and cancer syndromes as models to study gene–environment interactions
Carbone, M., Arron, S. T., Beutler, B., Bononi, A., Cavenee, W. K., Cleaver, J. E., Croce, C. M., D’Andrea, A. D., Foulkes, W. D., Gaudino, G., et al. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0265-y · Cited by 198
Self-citation
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma
Makinoshima, H., Takita, M., Saruwatari, K., Umemura, S., Obata, Y., Ishii, G., Matsumoto, S., Sugiyama, E., Ochiai, A., Abe, R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.660498 · Cited by 195
In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma
Sagiyama, K., Mashimo, T., Togao, O., Vemireddy, V., Hatanpaa, K. J., Maher, E. A., Mickey, B., Pan, E., Sherry, A. D., Bachoo, R. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323855111 · Cited by 194
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
Liang, J., Cao, R., Zhang, Y., Xia, Y., Zheng, Y., Li, X., Wang, L., Yang, W., & Lu, Z. (2016) · Nature Communications · doi:10.1038/ncomms12431 · Cited by 193
Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications
Ju, H., Lu, Y., Chen, D.-L., Zuo, Z.-X., Liu, Z., Wu, Q.-N., Mo, H., Wang, Z., Wang, D., Pu, H., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy160 · Cited by 190
VDAC1: from structure to cancer therapy
Shoshan‐Barmatz, V., & Mizrachi, D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00164 · Cited by 200
Hyperpolarized [1-13C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in Vivo
Bohndiek, S. E., Kettunen, M. I., Hu, D., Kennedy, B. W. C., Boren, J., Gallagher, F. A., & Brindle, K. M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2045925 · Cited by 190
TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis
Cheung, E. C., Athineos, D., Lee, P., Ridgway, R. A., Lambie, W., Nixon, C., Strathdee, D., Blyth, K., Sansom, O. J., & Vousden, K. H. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.05.001 · Cited by 193
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Xue, D., Zhou, X., & Qiu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110676 · Cited by 195
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 203
The Warburg Effect Revisited—Lesson from the Sertoli Cell
Oliveira, P. F., Martins, A. D., Moreira, A. C., Cheng, C. Y., & Alves, M. G. (2014) · Medicinal Research Reviews · doi:10.1002/med.21325 · Cited by 193
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
Lukey, M. J., Greene, K. S., Erickson, J. W., Wilson, K. F., & Cerione, R. A. (2016) · Nature Communications · doi:10.1038/ncomms11321 · Cited by 190
Clinical update on cancer: molecular oncology of head and neck cancer
Suh, Y., Amelio, I., Urbano, T. G., & Tavassoli, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.548 · Cited by 195
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 191
Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy
Rao, N. V., Ko, H., Lee, J., & Park, J. H. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00110 · Cited by 192
Mitochondrial Stress Response and Cancer
O’Malley, J., Kumar, R., Inigo, J. R., Yadava, N., & Chandra, D. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.009 · Cited by 197
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Mirzaei, S., Gholami, M. H., Zabolian, A., Saleki, H., Farahani, M. V., Hamzehlou, S., Far, F. B., Sharifzadeh, S. O., Samarghandian, S., Khan, H. Z., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105759 · Cited by 191
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
Ali, A., Levantini, E., Teo, J. T., Goggi, J., Clohessy, J. G., Wu, C., Chen, L., Yang, H. H., Krishnan, I., Kocher, O. N., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708313 · Cited by 187
Dysregulated Mitochondrial Dynamics and Metabolism in Obesity, Diabetes, and Cancer
Dai, W., & Jiang, L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00570 · Cited by 186
The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
Koepsell, H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.017 · Cited by 190
Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress
Marino, M. L., Pellegrini, P., Di Lernia, G., Djavaheri-Mergny, M., Brnjic, S., Zhang, X., Hägg, M., Linder, S., Fais, S., Codogno, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339127 · Cited by 184
Increased Oxidative Stress as a Selective Anticancer Therapy
Liu, J., & Wang, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/294303 · Cited by 191
Emerging Regulatory Paradigms in Glutathione Metabolism
Liu, Y., Hyde, A. S., Simpson, M. A., & Barycki, J. J. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-420117-0.00002-5 · Cited by 190
FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism
Zhang, C., Liao, Y., Liu, P., Du, Q., Liang, Y., Ooi, S., Qin, S., He, S., Yao, S., & Wang, W. (2020) · Theranostics · doi:10.7150/thno.44868 · Cited by 186
Glutathione-mediated nanomedicines for cancer diagnosis and therapy
Ding, Y., Dai, Y., Wu, M., & Li, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.128880 · Cited by 186
Applications and challenges of ultra-small particle size nanoparticles in tumor therapy
Xu, J., Song, M., Zhou, F., Zheng, L., Huang, X., & Liu, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.028 · Cited by 188
Famine versus feast: understanding the metabolism of tumors in vivo
Mayers, J. R., & Heiden, M. G. V. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.004 · Cited by 190
Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
Li, X., Chen, Y., Hu, P., & Huang, W. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0797 · Cited by 186
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update
Liu, M., Jiang, L., & Guan, X. (2014) · Protein & Cell · doi:10.1007/s13238-014-0065-9 · Cited by 183
A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process
Stuart, S. D., Schauble, A., Gupta, S., Kennedy, A. D., Keppler, B. R., Bingham, P. M., & Zachar, Z. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-4 · Cited by 188
Imaging hallmarks of cancer in living mice
Ellenbroek, S. I. J., & van Rheenen, J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3742 · Cited by 186
The Monocarboxylate Transporter 4 Is Required for Glycolytic Reprogramming and Inflammatory Response in Macrophages
Tan, Z., Xie, N., Banerjee, S., Cui, H., Fu, M., Thannickal, V. J., & Liu, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603589 · Cited by 189
Modeling cancer metabolism on a genome scale
Yizhak, K., Chaneton, B., Gottlieb, E., & Ruppin, E. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145307 · Cited by 187
Cancer stem cell metabolism: target for cancer therapy
Chae, Y. C., & Kim, J. H. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.7.112 · Cited by 185
A Tale of Two Glutaminases: Homologous Enzymes with Distinct Roles in Tumorigenesis
Katt, W. P., Lukey, M. J., & Cerione, R. A. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0190 · Cited by 179
Global proteomic assessment of the classical protein-tyrosine phosphatome and “Redoxome”
Karisch, R., Fernandez, M., Taylor, P., Virtanen, C., St-Germain, J. R., Jin, L. L., Harris, I. S., Mori, J., Mak, T. W., Senis, Y. A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.020 · Cited by 179
Self-citation
Metabolic differentiation in the embryonic retina
Agathocleous, M., Love, N. K., Randlett, O., Harris, J. J., Liu, J., Murray, A. J., & Harris, W. A. (2012) · Nature Cell Biology · doi:10.1038/ncb2531 · Cited by 182
Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
Wang, Z., Liu, F., Fan, N., Zhou, C., Li, D., MacVicar, T., Dong, Q., Bruns, C. J., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589508 · Cited by 189
The Hallmarks of Flavonoids in Cancer
Ponte, L. G. S., Pavan, I. C. B., Mancini, M. C. S., da Silva, L. G. S., Morelli, A. P., Severino, M. B., Bezerra, R. M. N., & Simabuco, F. M. (2021) · Molecules · doi:10.3390/molecules26072029 · Cited by 188
The MYCN Protein in Health and Disease
Ruiz-Pérez, M. V., Henley, A. B., & Arsenian‐Henriksson, M. (2017) · Genes · doi:10.3390/genes8040113 · Cited by 191
Tumor microenvironment and radioresistance
Suwa, T., Kobayashi, M., Nam, J., & Harada, H. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00640-9 · Cited by 186

Authors: Cairns, R. A., Harris, I. S., & Mak, T. W.
Corresponding author: Mak, Tak W.
ORCID: Cairns, Rob A.
Harris, Isaac S.
Mak, Tak W.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2011-01-24
Volume: 11
Issue: 2
Pages: 85-95
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2981
OpenAlex: W2028897202
Semantic Scholar: 9d36b5b10983f1aa90a9d9d5a7bcffe671b38257
Cited by: 4,744
References: 142
Citations by year: 2026: 95 · 2025: 192 · 2024: 234 · 2023: 276 · 2022: 293 · 2021: 418 · 2020: 423 · 2019: 386 · 2018: 386 · 2017: 414 · 2016: 399 · 2015: 387 · 2014: 318 · 2013: 251 · 2012: 192
FWCI: 19.59
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords: cancer metabolism, Warburg effect, redox homeostasis, tumor microenvironment, carcinogenesis, central metabolic pathways
MeSH terms: Cell Transformation, Neoplastic, Humans, Neoplasms, Oxidation-Reduction, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Intracellular Signaling Peptides and Proteins, Gene Regulatory Networks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of cancer cell metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks